How Much Does Kidney biopsy Cost in China?
Kidney biopsy in China typically costs from $750 to $1,600. The final price depends on hospital setting and pathology tests. Bundled consultations, lab tests, ultrasound, and observation also affect the total. Public and international departments in Beijing and Guangzhou may offer different packages. In the US, the average price is $4,300. Patients may save around 72% compared with US pricing. Packages may include ultrasound, biopsy, pathology, and brief observation.
- Public-hospital pricing: It may cover the needle procedure, ultrasound guidance, and basic pathology. Additional microscopy analysis can increase the bill because it requires more detailed tissue review.
- International departments: They may bundle specialist visits, pre-biopsy tests, pathology, and an inpatient stay. Added services raise the package total.
- Observation and room costs: Observation typically lasts 3–5 days. Each added hospital day adds room charges; public wards cost less than private accommodation.
- Extra testing and travel: Outside labs may charge extra for specialized genetic or molecular pathology. Hotel stays, travel, and post-biopsy medicines need separate budgeting.
| China | Turkey | Austria | |
|---|---|---|---|
| Kidney biopsy | ≈ $750 | from $1,200 | ≈ $1,300 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Kidney biopsy upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Kidney biopsy and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Kidney biopsy journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Discover the Best Kidney biopsy Clinics in China: 1 Verified Option and Prices
Our Trusted Doctors
View all Doctors
Liao Zhengyin
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Luo Xiaoping
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Xiao Yueyong
Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).
He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.
Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Fan Yu
Dr. Fan Yu is the Director of Kidney Transplantation at Xiamen Humanity Hospital. He led a team that completed 112 kidney transplants within two years. His center has ranked first in Fujian Province for transplant volume three years running. Dr. Yu pioneered the diagnosis of chronic and subclinical rejection in China.
- Completed over 110 successful kidney transplants and one combined liver–kidney procedure.
- Served as Director or Deputy Director at major Shanghai transplant centers.
- Vice Chairman of the Transplant Surgeon Branch of the Chinese Medical Doctor Association.
- Published over 30 SCI-indexed papers and led 10 national research grants.
Video Stories from Bookimed Patients
Share this content
Anna Leonova

